{{Rsnum
|rsid=1058932
|Gene=CYP2C8
|Chromosome=10
|position=96796861
|Orientation=minus
|GMAF=0.2787
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 67.0 | 31.2 | 1.8
| HCB | 33.3 | 51.9 | 14.8
| JPT | 30.4 | 50.0 | 19.6
| YRI | 38.4 | 45.2 | 16.4
| ASW | 53.6 | 39.3 | 7.1
| CHB | 33.3 | 51.9 | 14.8
| CHD | 38.9 | 50.0 | 11.1
| GIH | 50.5 | 35.6 | 13.9
| LWK | 44.4 | 48.1 | 7.4
| MEX | 63.0 | 35.2 | 1.9
| MKK | 53.9 | 36.4 | 9.7
| TSI | 67.6 | 31.4 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20436375
|Title=Genetic variance in CYP2C8 and increased risk of myocardial infarction
}}

{{PMID Auto
|PMID=17048007
|Title=Association of warfarin dose with genes involved in its action and metabolism.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}